Notice NOT-TW-21-006 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-111 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-230 from the NIH Guide for Grants and Contracts

Notice NOT-AG-21-023 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-044 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-21-186 from the NIH Guide for Grants and Contracts. This announcement for an R34 FOA solicits pilot studies that develop and test the effectiveness of multi-level systems interventions that predict suicide risk and/or connect. Black youth who are at risk for suicide and suicidal behaviors, to needed treatment and services to prevent suicide. The purpose of the companion R01 FOA is to provide resources for evaluating the feasibility, acceptability, and safety of novel community-based, systems level approaches to improving outcomes, assessing and modifying health risk behavior, and for obtaining the preliminary data needed as a prerequisite to a larger-scale (efficacy or effectiveness) services study. These must incorporate community or stakeholder advisory boards (which include members of the communities served, providers, youth, etc.), to help inform the development of the intervention.

Funding Opportunity RFA-MH-21-185 from the NIH Guide for Grants and Contracts. The announcement would solicit pilot studies that develop and test the effectiveness of multi-level systems interventions that predict suicide risk and/or connect. Black youth who are at risk for suicide and suicidal behaviors, to needed treatment and services to prevent suicide. There would be a companion R01 announcement. The purpose of the R01 FOA is to provide resources for evaluating the feasibility, acceptability, and safety of novel community-based, systems level approaches to improving outcomes, assessing and modifying health risk behavior, and for obtaining the preliminary data needed as a prerequisite to a larger-scale (efficacy or effectiveness) services study. These must incorporate community or stakeholder advisory boards (which include members of the communities served, providers, youth, etc.), to help inform the development of the intervention.

Notice NOT-CA-21-056 from the NIH Guide for Grants and Contracts

Notice NOT-LM-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-094 from the NIH Guide for Grants and Contracts

Funding Opportunity PAS-21-216 from the NIH Guide for Grants and Contracts. The primary objective of this FOA is to solicit research projects with the aim of elucidating the role of positive affect and related processes in suicidal individuals and evaluating modifiable behavioral and neural targets. Specifically, studies should include clinical populations with high risk of suicide, suicide attempters or acutely suicidal individuals, and may also include non-suicidal patients, high risk individuals in an absence of diagnosis, or healthy control groups. Projects across developmental spectrum are encouraged. Research projects should aim to 1) specify a construct of interest either in terms of research domain criteria: positive valence system (RDoC PVS), or a symptom relevant construct, such as an anhedonia/ anhedonia subtype, cognitive process such as present/future reward decision making, generating reasons for living in the context of anticipation of positive experiences, etc. 2) demonstrate that measures of the construct are reliable and reproducible and engage brain subsystem relevant to positive affect, and/or 3) show active modification of targeted brain system and behavioral measures of the construct through behavioral training or other means such as use of non-invasive neuromodulation, pharmacological or psychosocial therapeutic probes. Behavioral tasks used may include both novel and established tasks within the RDoC positive valence domain (e.g. reward sensitivity, reward valuation, and reward learning) and/or tasks probing components and subconstructs of hedonic and related processes. Use of measures of the dynamic changes in PA is strongly encouraged to further establish co-occurrence with other risk factors and suicidality.

Funding Opportunity PAS-21-215 from the NIH Guide for Grants and Contracts. The primary objective of this FOA is to solicit research projects with the aim of elucidating the role of positive affect and related processes in suicidal individuals and evaluating modifiable behavioral and neural targets. Specifically, studies should include clinical populations with high risk of suicide, suicide attempters or acutely suicidal individuals, and may also include non-suicidal patients, high risk individuals in an absence of diagnosis, or healthy control groups. Projects across developmental spectrum are encouraged. Research projects should aim to 1) specify a construct of interest either in terms of research domain criteria: positive valence system (RDoC PVS), or a symptom relevant construct, such as an anhedonia/ anhedonia subtype, cognitive process such as present/future reward decision making, generating reasons for living in the context of anticipation of positive experiences, etc. 2) demonstrate that measures of the construct are reliable and reproducible and engage brain subsystem relevant to positive affect, and/or 3) show active modification of targeted brain system and behavioral measures of the construct through behavioral training or other means such as use of non-invasive neuromodulation, pharmacological or psychosocial therapeutic probes. Behavioral tasks used may include both novel and established tasks within the RDoC positive valence domain (e.g. reward sensitivity, reward valuation, and reward learning) and/or tasks probing components and subconstructs of hedonic and related processes. Use of measures of the dynamic changes in PA is strongly encouraged to further establish co-occurrence with other risk factors and suicidality.

Notice NOT-AA-21-014 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HD-22-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved clinical biomarkers and companion biomarker diagnostics (e.g., point of care and/or direct-to-consumer tests, DTC) to support the clinical development of non-hormonal contraceptive product(s) for men and women.

Notice NOT-AA-21-013 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-186 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences

Notice NOT-DA-21-041 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-106 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-055 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-043 from the NIH Guide for Grants and Contracts